2.39
-0.22 (-8.43%)
-0.22 (-8.43%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 125,715 |
|
|||||
| News | - | ||||||
| Day High | 2.67 | Low High |
|||||
| Day Low | 2.30 | ||||||
Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Gemini Therapeutics Inc | GMTX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| -0.22 | -8.43% | 2.39 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.67 | 2.30 | 2.67 | 2.39 | 2.61 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,924 | 125,715 | $ 2.49 | $ 313,473 | - | 2.30 - 19.085 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:23:19 | 2 | $ 2.44 | USD |
Period:
Draw Mode:
Gemini Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 103.04M | 43.11M | 22.15M | $ - | $ - | -0.60 | -1.80 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 176.95k | 0.30% |
Gemini Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical GMTX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.99 | 3.10 | 2.30 | 2.68 | 118,077 | -0.60 | -20.07% |
| 1 Month | 3.86 | 4.05 | 2.30 | 3.26 | 120,685 | -1.47 | -38.08% |
| 3 Months | 5.08 | 5.16 | 2.30 | 3.92 | 131,757 | -2.69 | -52.95% |
| 6 Months | 11.91 | 12.90 | 2.30 | 5.89 | 324,674 | -9.52 | -79.93% |
| 1 Year | 12.15 | 19.085 | 2.30 | 8.36 | 295,009 | -9.76 | -80.33% |
| 3 Years | 12.15 | 19.085 | 2.30 | 8.36 | 295,009 | -9.76 | -80.33% |
| 5 Years | 12.15 | 19.085 | 2.30 | 8.36 | 295,009 | -9.76 | -80.33% |
Gemini Therapeutics Description
| Gemini Therapeutics Inc is a clinical-stage precision medicine company developing novel therapeutic compounds to treat genetically defined AMD. Its candidate, GEM103, is a recombinant form of the Complement Factor H protein (CFH) and is designed to address both complement hyperactivity and restore retinal health. |
